Glycol and hydroxyphosphonate peptidomimetics as inhibitors of aspartyl proteases
Compounds of Formula I are disclosed as inhibitors having activity against the aspartyl proteases, plasmepsin and cathepsin D. The compounds are therefore useful for treatment of diseases such as malaria and Alzheimer's disease. In preferred compounds of Formula I, Y is an dialkoxyphosphonate,...
Gespeichert in:
| Hauptverfasser: | , , , , , , , |
|---|---|
| Format: | Patent |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext bestellen |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | |
|---|---|
| container_issue | |
| container_start_page | |
| container_title | |
| container_volume | |
| creator | DOLLE, III ROLAND ELLWOOD SHIMSHOCK YVONNE CLASS HERPIN TIMOTHEE FELIX CARROLL CAROLYN DIIANNI |
| description | Compounds of Formula I are disclosed as inhibitors having activity against the aspartyl proteases, plasmepsin and cathepsin D. The compounds are therefore useful for treatment of diseases such as malaria and Alzheimer's disease. In preferred compounds of Formula I, Y is an dialkoxyphosphonate, or alpha -hydroxyamide group and Z is an acyl or alpha -ketocarbamate functionality. Intermediates in the solid phase synthesis of compounds of Formula I, in which compounds are attached to a solid support, are also disclosed. |
| format | Patent |
| fullrecord | <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_US5962506A</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>US5962506A</sourcerecordid><originalsourceid>FETCH-epo_espacenet_US5962506A3</originalsourceid><addsrcrecordid>eNqFirsKAjEQANNYiPoN7g8IotyBpYiPVtT6WJM9EshlQ3YL8_emsLcYBoaZm_s1VssRMDnw1RX-1OxZGgmVIFPW4HgKE2mwAigQkg_voFwEeGwhY9EaIRdWQiFZmtmIUWj188KsL-fn6bahzAO13VIiHV6P7tDvum1_3P8_vrGzOHs</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>Glycol and hydroxyphosphonate peptidomimetics as inhibitors of aspartyl proteases</title><source>esp@cenet</source><creator>DOLLE, III; ROLAND ELLWOOD ; SHIMSHOCK; YVONNE CLASS ; HERPIN; TIMOTHEE FELIX ; CARROLL; CAROLYN DIIANNI</creator><creatorcontrib>DOLLE, III; ROLAND ELLWOOD ; SHIMSHOCK; YVONNE CLASS ; HERPIN; TIMOTHEE FELIX ; CARROLL; CAROLYN DIIANNI</creatorcontrib><description>Compounds of Formula I are disclosed as inhibitors having activity against the aspartyl proteases, plasmepsin and cathepsin D. The compounds are therefore useful for treatment of diseases such as malaria and Alzheimer's disease. In preferred compounds of Formula I, Y is an dialkoxyphosphonate, or alpha -hydroxyamide group and Z is an acyl or alpha -ketocarbamate functionality. Intermediates in the solid phase synthesis of compounds of Formula I, in which compounds are attached to a solid support, are also disclosed.</description><edition>6</edition><language>eng</language><subject>ACYCLIC OR CARBOCYCLIC COMPOUNDS ; ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAININGELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN,SULFUR, SELENIUM OR TELLURIUM ; CHEMISTRY ; COMPOSITIONS BASED THEREON ; HETEROCYCLIC COMPOUNDS ; HUMAN NECESSITIES ; HYGIENE ; MACROMOLECULAR COMPOUNDS OBTAINED BY REACTIONS ONLY INVOLVINGCARBON-TO-CARBON UNSATURATED BONDS ; MEDICAL OR VETERINARY SCIENCE ; METALLURGY ; ORGANIC CHEMISTRY ; ORGANIC MACROMOLECULAR COMPOUNDS ; PEPTIDES ; PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES ; THEIR PREPARATION OR CHEMICAL WORKING-UP</subject><creationdate>1999</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=19991005&DB=EPODOC&CC=US&NR=5962506A$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,308,776,881,25542,76289</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=19991005&DB=EPODOC&CC=US&NR=5962506A$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>DOLLE, III; ROLAND ELLWOOD</creatorcontrib><creatorcontrib>SHIMSHOCK; YVONNE CLASS</creatorcontrib><creatorcontrib>HERPIN; TIMOTHEE FELIX</creatorcontrib><creatorcontrib>CARROLL; CAROLYN DIIANNI</creatorcontrib><title>Glycol and hydroxyphosphonate peptidomimetics as inhibitors of aspartyl proteases</title><description>Compounds of Formula I are disclosed as inhibitors having activity against the aspartyl proteases, plasmepsin and cathepsin D. The compounds are therefore useful for treatment of diseases such as malaria and Alzheimer's disease. In preferred compounds of Formula I, Y is an dialkoxyphosphonate, or alpha -hydroxyamide group and Z is an acyl or alpha -ketocarbamate functionality. Intermediates in the solid phase synthesis of compounds of Formula I, in which compounds are attached to a solid support, are also disclosed.</description><subject>ACYCLIC OR CARBOCYCLIC COMPOUNDS</subject><subject>ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAININGELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN,SULFUR, SELENIUM OR TELLURIUM</subject><subject>CHEMISTRY</subject><subject>COMPOSITIONS BASED THEREON</subject><subject>HETEROCYCLIC COMPOUNDS</subject><subject>HUMAN NECESSITIES</subject><subject>HYGIENE</subject><subject>MACROMOLECULAR COMPOUNDS OBTAINED BY REACTIONS ONLY INVOLVINGCARBON-TO-CARBON UNSATURATED BONDS</subject><subject>MEDICAL OR VETERINARY SCIENCE</subject><subject>METALLURGY</subject><subject>ORGANIC CHEMISTRY</subject><subject>ORGANIC MACROMOLECULAR COMPOUNDS</subject><subject>PEPTIDES</subject><subject>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><subject>THEIR PREPARATION OR CHEMICAL WORKING-UP</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>1999</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNqFirsKAjEQANNYiPoN7g8IotyBpYiPVtT6WJM9EshlQ3YL8_emsLcYBoaZm_s1VssRMDnw1RX-1OxZGgmVIFPW4HgKE2mwAigQkg_voFwEeGwhY9EaIRdWQiFZmtmIUWj188KsL-fn6bahzAO13VIiHV6P7tDvum1_3P8_vrGzOHs</recordid><startdate>19991005</startdate><enddate>19991005</enddate><creator>DOLLE, III; ROLAND ELLWOOD</creator><creator>SHIMSHOCK; YVONNE CLASS</creator><creator>HERPIN; TIMOTHEE FELIX</creator><creator>CARROLL; CAROLYN DIIANNI</creator><scope>EVB</scope></search><sort><creationdate>19991005</creationdate><title>Glycol and hydroxyphosphonate peptidomimetics as inhibitors of aspartyl proteases</title><author>DOLLE, III; ROLAND ELLWOOD ; SHIMSHOCK; YVONNE CLASS ; HERPIN; TIMOTHEE FELIX ; CARROLL; CAROLYN DIIANNI</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_US5962506A3</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>eng</language><creationdate>1999</creationdate><topic>ACYCLIC OR CARBOCYCLIC COMPOUNDS</topic><topic>ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAININGELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN,SULFUR, SELENIUM OR TELLURIUM</topic><topic>CHEMISTRY</topic><topic>COMPOSITIONS BASED THEREON</topic><topic>HETEROCYCLIC COMPOUNDS</topic><topic>HUMAN NECESSITIES</topic><topic>HYGIENE</topic><topic>MACROMOLECULAR COMPOUNDS OBTAINED BY REACTIONS ONLY INVOLVINGCARBON-TO-CARBON UNSATURATED BONDS</topic><topic>MEDICAL OR VETERINARY SCIENCE</topic><topic>METALLURGY</topic><topic>ORGANIC CHEMISTRY</topic><topic>ORGANIC MACROMOLECULAR COMPOUNDS</topic><topic>PEPTIDES</topic><topic>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</topic><topic>THEIR PREPARATION OR CHEMICAL WORKING-UP</topic><toplevel>online_resources</toplevel><creatorcontrib>DOLLE, III; ROLAND ELLWOOD</creatorcontrib><creatorcontrib>SHIMSHOCK; YVONNE CLASS</creatorcontrib><creatorcontrib>HERPIN; TIMOTHEE FELIX</creatorcontrib><creatorcontrib>CARROLL; CAROLYN DIIANNI</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>DOLLE, III; ROLAND ELLWOOD</au><au>SHIMSHOCK; YVONNE CLASS</au><au>HERPIN; TIMOTHEE FELIX</au><au>CARROLL; CAROLYN DIIANNI</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>Glycol and hydroxyphosphonate peptidomimetics as inhibitors of aspartyl proteases</title><date>1999-10-05</date><risdate>1999</risdate><abstract>Compounds of Formula I are disclosed as inhibitors having activity against the aspartyl proteases, plasmepsin and cathepsin D. The compounds are therefore useful for treatment of diseases such as malaria and Alzheimer's disease. In preferred compounds of Formula I, Y is an dialkoxyphosphonate, or alpha -hydroxyamide group and Z is an acyl or alpha -ketocarbamate functionality. Intermediates in the solid phase synthesis of compounds of Formula I, in which compounds are attached to a solid support, are also disclosed.</abstract><edition>6</edition><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext_linktorsrc |
| identifier | |
| ispartof | |
| issn | |
| language | eng |
| recordid | cdi_epo_espacenet_US5962506A |
| source | esp@cenet |
| subjects | ACYCLIC OR CARBOCYCLIC COMPOUNDS ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAININGELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN,SULFUR, SELENIUM OR TELLURIUM CHEMISTRY COMPOSITIONS BASED THEREON HETEROCYCLIC COMPOUNDS HUMAN NECESSITIES HYGIENE MACROMOLECULAR COMPOUNDS OBTAINED BY REACTIONS ONLY INVOLVINGCARBON-TO-CARBON UNSATURATED BONDS MEDICAL OR VETERINARY SCIENCE METALLURGY ORGANIC CHEMISTRY ORGANIC MACROMOLECULAR COMPOUNDS PEPTIDES PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES THEIR PREPARATION OR CHEMICAL WORKING-UP |
| title | Glycol and hydroxyphosphonate peptidomimetics as inhibitors of aspartyl proteases |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-11T08%3A37%3A46IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=DOLLE,%20III;%20ROLAND%20ELLWOOD&rft.date=1999-10-05&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3EUS5962506A%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true |